UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Annals of oncology, 2011-03, Vol.22 (3), p.636-642

2011

Volltextzugriff (PDF)

Small‐cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases

International journal of gynecological cancer, 2005-03, Vol.15 (2), p.295-300

2005

Volltextzugriff (PDF)

Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study

British journal of cancer, 2005-10, Vol.93 (9), p.999-1004

2005

Volltextzugriff (PDF)

Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium

International journal of gynecological cancer, 2006-03, Vol.16 (2), p.821-826

2006

Volltextzugriff (PDF)

Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma

International journal of gynecological cancer, 2006-01, Vol.16 (1), p.391-395

2006

Volltextzugriff (PDF)

Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables

Journal of cancer research and clinical oncology, 2002-06, Vol.128 (6), p.307-312

2002

Volltextzugriff (PDF)

Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters

British journal of cancer, 2002-07, Vol.87 (1), p.81-85

2002

Volltextzugriff (PDF)

Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations

European journal of gynaecological oncology, 2001, Vol.22 (3), p.217

2001

Volltextzugriff (PDF)

Cyclin D1 Expression in Endometrioid-type Endometrial Adenocarcinoma is Correlated with Histological Grade and Proliferative Activity, but not with Prognosis

Anticancer research, 2004-07, Vol.24 (4), p.2185-2191

2004

Volltextzugriff (PDF)

PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus

Journal of cancer research and clinical oncology, 2004-03, Vol.130 (3), p.161-168

2004

Volltextzugriff (PDF)

Concomitant Expression of HER2 and HIF-1 is a Poor Prognostic Factor in Uterine Cervical Carcinoma Treated with Concurrent Chemoradiotherapy: Prospective Analysis (KGROG0501)

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S358-S359

2008

Volltextzugriff (PDF)

Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis

European journal of gynaecological oncology, 2008, Vol.29 (3), p.222

2008

Volltextzugriff (PDF)

Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance

Journal of cancer research and clinical oncology, 2003-04, Vol.129 (4), p.222-226

2003

Volltextzugriff (PDF)

Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma

International journal of gynecological cancer, 2006-02, Vol.16 (S1), p.452-457

2006

Volltextzugriff (PDF)

Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium

International journal of gynecological cancer, 2006-03, Vol.16 (2), p.821-826

2006

Volltextzugriff (PDF)

Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma

International journal of gynecological cancer, 2006, Vol.16 (1), p.391-395

2006

Volltextzugriff (PDF)

Lymph node pathway in the spread of endometrial carcinoma

European journal of gynaecological oncology, 2005, Vol.26 (2), p.167-169

2005

Volltextzugriff (PDF)

Parametrial spread is a prognostic factor in endometrial carcinoma

European journal of gynaecological oncology, 2003, Vol.24 (3-4), p.241

2003

Volltextzugriff (PDF)

C-kit overexpression in neuroendocrine small cell carcinoma of the uterine cervix

European journal of gynaecological oncology, 2006, Vol.27 (1), p.53-55

2006

Volltextzugriff (PDF)

Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases

International journal of gynecological cancer, 2005-02, Vol.15 (2), p.295-300

2005

Volltextzugriff (PDF)

8021 The effect of anemia on the progression-free survival in epithelial ovarian cancer (stage II-IV) patients treated with paclitaxel-carboplatin combination therapy: a retrospective analysis of the JGOG3016 trial of the Japanese Gynecologic Oncology Group (JGOG3016-A)

European journal of cancer supplements, 2009, Vol.7 (2), p.456-456

2009

Volltextzugriff (PDF)

Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma

International journal of gynecological cancer, 2006-01, Vol.16 (Suppl 1), p.452-457

2006

Volltextzugriff (PDF)

Medroxyprogesterone acetate stimulates cdk inhibitors, p21 and p27, in endometrial carcinoma cells transfected with progesterone receptor-B cDNA

European journal of gynaecological oncology, 2006, Vol.27 (1), p.33-38

2006

Volltextzugriff (PDF)

Optimal dose for stage IIIB adenocarcinoma of the uterine cervix on the basis of biological effective dose

European journal of gynaecological oncology, 2006, Vol.27 (1), p.47

2006

Volltextzugriff (PDF)

Treatment for complex atypical hyperplasia of the endometrium

European journal of gynaecological oncology, 2001, Vol.22 (5), p.365

2001

Volltextzugriff (PDF)

1 – 25 von 200

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Englisch
(153)
Japanisch
(61)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Small‐cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases

Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study

Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium

Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma

Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables

Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters

Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations

Cyclin D1 Expression in Endometrioid-type Endometrial Adenocarcinoma is Correlated with Histological Grade and Proliferative Activity, but not with Prognosis

PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus

Concomitant Expression of HER2 and HIF-1 is a Poor Prognostic Factor in Uterine Cervical Carcinoma Treated with Concurrent Chemoradiotherapy: Prospective Analysis (KGROG0501)

Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis

Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance

Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma

Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium

Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma

Lymph node pathway in the spread of endometrial carcinoma

Parametrial spread is a prognostic factor in endometrial carcinoma

C-kit overexpression in neuroendocrine small cell carcinoma of the uterine cervix

Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases

8021 The effect of anemia on the progression-free survival in epithelial ovarian cancer (stage II-IV) patients treated with paclitaxel-carboplatin combination therapy: a retrospective analysis of the JGOG3016 trial of the Japanese Gynecologic Oncology Group (JGOG3016-A)

Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma

Medroxyprogesterone acetate stimulates cdk inhibitors, p21 and p27, in endometrial carcinoma cells transfected with progesterone receptor-B cDNA

Optimal dose for stage IIIB adenocarcinoma of the uterine cervix on the basis of biological effective dose

Treatment for complex atypical hyperplasia of the endometrium

Suchergebnisse filtern